News Daily News ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients Michael O'Riordan April 11, 2017
News Daily News ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events Michael O'Riordan April 04, 2017
News Daily News Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA Michael O'Riordan March 15, 2017
News Daily News Improvement in STEMI Care Processes Possible on a Large Scale Todd Neale January 18, 2017
News Features Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter Michael O'Riordan January 10, 2017
News Daily News Multiple Antithrombotic Meds Before PCI in NSTE ACS Ups Bleeding Risk, Lowers Survival Michael O'Riordan December 13, 2016
News Conference News AHA 2016 Stress Testing May Be Increasing Among Younger Patients With Commercial Health Insurance L.A. McKeown November 23, 2016
News Conference News AHA 2016 La Pruebas de Esfuerzo podrían estar Aumentando en Pacientes Más Jóvenes con Seguro Médico Comercial L.A. McKeown November 23, 2016
News Conference News AHA 2016 ¿Dolor Muscular Secundario a las Estatinas? Según el Análisis GAUSS-3 Podría ser Genético Michael O'Riordan November 22, 2016
News Conference News AHA 2016 Statin-Associated Muscle Pain? It May Be Your Genes, Says GAUSS-3 Analysis Michael O'Riordan November 22, 2016
News Conference News AHA 2016 Chest Pain Clinic Reduces Emergency Department and Hospital ‘Frequent Fliers’ Michael O'Riordan November 21, 2016
News Conference News AHA 2016 Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women L.A. McKeown November 17, 2016
News Conference News AHA 2016 Según Datos a Nivel Nacional, las PCI realizadas en Centros Sin Soporte Quirúrgico ‘Probablemente No Tengan Problemas’ Yael L. Maxwell November 16, 2016
News Conference News AHA 2016 PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests Yael L. Maxwell November 16, 2016
Presentation AHA 2016 Arterial Revascularization Trial (ART) Presenter: David P. Taggart November 15, 2016
Presentation AHA 2016 The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I) Presenter: Michael Gibson November 15, 2016
Presentation AHA 2016 FUnctional Testing Underlying REvascularization: The FUTURE trial Presenter: Gilles Rioufol November 15, 2016